Bharat Parenterals Limited has submitted a regulatory disclosure to the Corporate Relations Department of BSE Limited regarding scheduled interactions with analysts and investors. The disclosure is made in compliance with Regulation 30 read with Schedule III of the SEBI LODR (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company representatives will participate in physical one-on-one and group meetings with investors and analysts according to the following schedule:
- Date & Time: August 13, 2026 from 10:00 AM
- Type of Interaction: Investors/Analysts Meetings
- Organizer/Host: Emkay Global Financial Services Ltd.
- Location: Mumbai
- Mode: Physical
The company explicitly states that no unpublished price-sensitive information (UPSI) will be shared by the company or its representatives during these interactions.
The notice includes a disclaimer that the investor meetings are subject to last-minute changes due to exigencies on the part of either the investors or the company. The same information is available on the company's website at www.bplindia.in.
The letter is signed by Mr. Sharmin Nareshkumar Soni, Company Secretary & Compliance Officer (ICSI M.No: A-75694), from Vadodara, and is digitally signed with timestamp August 10, 2026 at 16:31:50 +05:30.